The purpose of this study was to evaluate the clinical and magnetic resonance imaging (MRI) findings of soft tissue metastases distinct from benign soft tissue lesions.
INTRODUCTION
Metastatic tumors presenting as soft tissue masses are relatively rare compared to bony metastasis or direct invasion by carcinoma (1) (2) (3) . They are usually misdiagnosed as a soft tissue sarcoma on imaging studies, and can be the source of diagnostic confusion both clinically and pathologically. The distinction between a soft tissue metastasis and primary soft tissue tumor or inflammation is important, because the treatment and prognosis are significantly different (1, 4, 5) . Moreover, the metastatic tumors to soft tissue are known to have poor prognosis (1, 6) .
However, in most cases, the distinction between a primary soft tissue sarcoma and metastatic carcinoma is difficult without biopsy (6).
Although there have been several case reports of skeletal muscle metastases from lung, breast, colonic, renal, ovarian, gastric, esophagus, melanoma, and sarcoma (3, 5, (7) (8) (9) (10) (11) (12) , imaging findings of soft tissue metastases, including magnetic resonance imaging (MRI) and computed tomography (CT) appearance are usually non-specific (13) . Also, to our knowledge, there are few original reports about the features of MRI for soft tissue metastasis involving muscle or subcutaneous fat layer. In this study, we evaluated clinical data and MRI findings of soft tissue metastases distinct from benign soft tissue lesions.
Soft Tissue Metastasis in Patients with

MATERIALS AND METHODS
Patients
This study was approved by our Institutional Review Board (No. E-2017011), and informed consent was waived due to retrospective study.
We retrospectively evaluated the soft tissue lesions inciden- We defined multiple lesions as having more than one soft tissue lesion within the scan range. The size of the lesion was defined as the longest diameter by measuring the long axis. In a patient with multiple lesions, the largest lesion was analyzed.
The margin of a lesion was simply classified as well-or ill-defined. Well-defined margin was defined as the case where the entire lesion was clearly bounded to the surrounding normal structures and ill-defined margin was defined as a case where some or all the lesion was unclear or ambiguous to the surrounding normal structure. The locations of a lesion were basically investigated based on anatomical locations and classified as deep (deep to compartmental fascia) or superficial (involving skin and subcutaneous fat).
The homogeneity of the lesion was simply classified as homogeneous and heterogeneous, and assessed on both T1 weighted images (T1WIs) and T2 weighted images (T2WIs and pilomatricoma (n = 1).
The types of primary malignancies and the number of patients diagnosed with soft tissue metastasis according to each primary malignancy are summarized in Table 1 . Among all primary tumors, lung cancer was the most common (26%) and the majority of soft tissue metastasis originated from lung cancer (31%). The pathologic results of three unknown primary origin were poorly differentiated squamous cell carcinoma, melanoma, and primitive neuroectodermal tumor (PNET).
The anatomical locations of soft tissue lesions are summarized in Table 2 . Metastatic soft tissue lesions (n = 36) were the most common in the lower extremities (thigh, lower leg, ankle, and toe; 13/36, 36%), followed by the shoulder (6/36, 17%) and the upper extremities (upperarm, forearm, finger, hand, and wrist; 5/36, 14%).
Among 36 patients with soft tissue metastases, 11 complained of pain. In the control group, 14 patients had pain. The symptom was not significant for differentiating between metastatic and Thirteen of 36 patients (36%) diagnosed with soft tissue metastasis had distant metastasis to bone or other solid organs (Fig. 2) .
Results of statistical analyses todifferentiate between soft tissue metastasis and benign soft tissue lesion are summarized in Table 3 . Age, lesion size, margin, degenerative change within the mass, and the presence of edema around soft tissue lesions ( Fig. 1) were statistically significant.
DISCUSSION
Distant metastases to soft tissue are relatively uncommon, even in patients with known cancers and despite comprising approximately 55% of our body mass (2, 14) . Some previous studies reported a relatively broad range of frequency, and these frequency differences might be considered to depend on the procedures used for the examinations or active examinations or autopsy cases (1, 3, 4) . Several factors may contribute to the rarity of hematogenous metastases to soft tissue areas. For example, organs with a high incidence for metastatic carcinomas, such as the liver, lung, or bone, are rich in capillary vasculature and have a constant blood flow, whereas in soft tissues, such as skeletal muscle, the blood flow is variable and subject to variations in tissue pressure affecting tumor implantation (6, 8, 14, 15) . Also, some authors suggested that lactic acid production by muscle inhibits growth of tumor studies, and uncommon hematogenous metastases to muscles are thought to be due to muscle motion, muscle pH, and the muscle's ability to remove tumorproduced lactic acid (11, 14, 16, 17) . Leukemia and lymphoma are the most frequent cancer of metastases to muscle (11) .
With regard to the primary malignant tumor, several studies (1, 6, 13, 18, 19) reported that the most frequent tumor of origin was lung cancer, similar to our series. However, many other studies reported different tendencies for the common source causing soft tissue metastases (1, 2, 13), and a variety of malignant (13, (20) (21) (22) (23) . In our study, the most commones tumors metastasizing to soft tissue were carcinomas of the lung and colon. In one study (2) , malignant melanoma was the most frequently specific tumor type that metastasized to soft tissue. However, there were only two cases of melanoma metastasis to soft tissue in our study.
Many metastatic tumors to soft tissue present as occult metastases from an unrecognized primary (2, 7, 24) . Also, in this The frequent metastatic site varies (1, 2, 13), with the thigh muscles, iliopsoas, and paraspinous muscles reported as common sites (3, 6, 20, 21, 26) . In this study, the most frequent site of metastasis to soft tissue area was the lower extremity, followed by the shoulder. These results contrast with previous studies (1, 2, 11, 13). These differences might be caused by the composition of the primary cancer. In this study, among 36 patients with soft tissue metastasis, 11 patients had lung cancer. In these patients the lesions were located in a lower leg (n = 4), shoulder (n = 3), thigh (n = 2), pelvic area (n = 1), and psoas muscles (n = 1). Given the ease of arterial metastasis of lung cancer, lesions can easily metastasize to distal extremities. In our study, the proportion of the lung cancer in primary malignancies was high, which might affect the anatomical site of the soft tissue metastasis. The anatomic distribution of metastases to soft tissue area in this study was similar to the distribution of soft tissue sarcoma, with 36% occurring in the lower extremity. Thus, metastatic carcinoma can often be confused clinically and histologically with primary soft tissue sarcoma. Soft tissue metastases can occur in muscles and subcutaneous sites, but the incidence of subcutaneous fat involvement has been reported to be lower than that of muscle involvement. It is believed that subcutaneous metastases might be underreported in the literature (13) .
Several authors (13, 27) suggested that soft tissue metastases, especially those in skeletal muscle, are frequently painful or palpable, and a painful soft tissue mass is more commonly noted in patients with soft tissue metastasis than in primary sarcoma (19) . In this study, 20 of 36 patients (56%) with soft tissue metastases complained of pain or palpable mass. However, the presence of symptom was not significant, and we could not compare symptoms between sarcoma and soft tissue metastases because our study did not include sarcomas. Clinical presentation, anatomic distribution, and radiographic imaging studies of metastases to soft tissue area are similar to those of soft tissue sarcomas (6) . Because the treatment and prognosis are different, differentiating between these diseases is important, but difficult (3, 6) . Moreover, the metastases of carcinomas to soft tissue appears to be a late event in the progression of the disease and the overall prognosis is poor (2, 6, 18) . However, distant metastases to other sites occurred only in 36% of our cases.
MRI has become the preferred technique for distinguishing soft tissue metastases from other tumorous processes (28) . In several previous studies (11, 13, 19, 24, 29) 
